MétaCan
Menu
← Back to cohort
Record W3114499032 · doi:10.21203/rs.3.rs-39369/v1

Administration of C5a Receptor Antagonist Improves the Efficacy of Human iPSCS-derived NS/PC Transplantation in the Acute Phase Of spinal Cord Injury

2020· preprint· en· W3114499032 on OpenAlexaff
Reo Shibata, Narihito Nagoshi, Keita Kajikawa, Shuhei Ito, Mohammad Rasool Khazaei, Satoshi Nori, Jun Kohyama, Michael G. Fehlings, Morio Matsumoto, Masaya Nakamura, Hideyuki Okano

Bibliographic record

VenueResearch Square · 2020
Typepreprint
Languageen
FieldMedicine
TopicSpinal Cord Injury Research
Canadian institutionsUniversity Health Network
Fundersnot available
KeywordsAntagonistSpinal cord injuryMedicineTransplantationSpinal cordAnesthesiaPharmacologyReceptorInternal medicine

Abstract

fetched live from OpenAlex

Abstract Background: We previously reported the efficacy of human-induced pluripotent stem cells derived neural stem/progenitor cells (hiPSC-NS/PCs) transplantation for spinal cord injury (SCI) in the subacute phase. However, this procedure is not effective in the acute phase due to the inflammatory response occurring immediately after SCI, which negatively impacts transplanted cell survival. C5a, which is one of the complement components, is a powerful chemoattractant which recruits inflammatory cells through binding of the C5a receptor. We hypothesized that suppression of the inflammatory response immediately after SCI using a C5a receptor antagonist (C5aRA) as an immunosuppressant would improve the efficacy of hiPSC-NS/PCs transplantation for SCI in the acute phase.Methods: Immunodeficient SCID-Beige mice underwent contusion SCI at T10 and received C5aRA immediately after SCI. Inflammatory cytokines and inflammatory cells in the injured spinal cord tissue during the acute phase were quantified using quantitative PCR and flow-cytometry. Next, we randomly and blindly divided the SCI mice into 4 groups (PBS only, C5aRA only, PBS + transplantation (PBS+TP), C5aRA + transplantation (C5aRA+TP)). Immediately after SCI, C5aRA or PBS was injected intraperitoneally once a day for 4 consecutive days, and then, 5.0 × 105 hiPSC-NS/PCs were transplanted into the lesion epicenter on day 4 in the PBS+TP and C5aRA+TP groups. We evaluated cell survival rate, hindlimb motor function, and the differentiation profile of the graft hiPSC-NS/PCs.Results: C5aRA administration significantly reduced several inflammatory cytokines such as IL-1b, IL-6 and TNFα, as well as inflammatory cells after SCI. Within the transplantation groups, the C5aRA+TP group had better functional improvement as compared to the PBS only group. The C5aRA+TP group also had a significantly higher cell survival rate compared to the PBS+TP group. There were no significant differences in the differentiation profiles of grafted hiPSC-NS/PCs between the C5aRA+TP and PBS+TP groups.Conclusion: This study demonstrates that administration of C5aRA can suppress the inflammatory response during the acute phase of SCI, and also improve the survival rate of transplanted hiPSC-NS/PCs as well as enhance motor functional restoration. hiPSC-NS/PC transplantation with C5aRA is a promising treatment during the acute injury phase for SCI patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.162
GPT teacher head0.526
Teacher spread0.364 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueResearch Square→Same topicSpinal Cord Injury Research→French-language works237,207→